Terms: = Liver cancer AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2
143 results:
1. Racial and ethnic disparities in alcohol-associated liver disease in the United States: A systematic review and meta-analysis.
Anouti A; Seif El Dahan K; Rich NE; Louissaint J; Lee WM; Lieber SR; Arab JP; Zhang BY; Patel MJ; Thimphittaya C; Díaz LA; Gregory DL; Kozlitina J; VanWagner LB; King AC; Mitchell MC; Singal AG; Cotter TG
Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38497931
[TBL] [Abstract] [Full Text] [Related]
2. SERPINE2 promotes liver cancer metastasis by inhibiting c-cbl-mediated EGFR ubiquitination and degradation.
Zhang S; Jia X; Dai H; Zhu X; Song W; Bian S; Wu H; Chen S; Tang Y; Chen J; Jin C; Zhou M; Xie H; Zheng S; Song P
Cancer Commun (Lond); 2024 Mar; 44(3):384-407. PubMed ID: 38407942
[TBL] [Abstract] [Full Text] [Related]
3. Featured lncRNA-based signature for discriminating prognosis and progression of hepatocellular carcinoma.
Qiu H; Jiang B; Chen Y; Lin Z; Zheng W; Cao X
J Appl Genet; 2024 May; 65(2):355-366. PubMed ID: 38347289
[TBL] [Abstract] [Full Text] [Related]
4. The incremental healthcare cost associated with cancer in Belgium: A registry-based data analysis.
Gorasso V; Vandevijvere S; Van der Heyden J; Pelgrims I; Hilderink H; Nusselder W; Demoury C; Schmidt M; Vansteelandt S; De Smedt D; Devleesschauwer B
Cancer Med; 2024 Feb; 13(3):e6659. PubMed ID: 38268318
[TBL] [Abstract] [Full Text] [Related]
5. Development of a machine learning-based model for predicting risk of early postoperative recurrence of hepatocellular carcinoma.
Zhang YB; Yang G; Bu Y; Lei P; Zhang W; Zhang DY
World J Gastroenterol; 2023 Nov; 29(43):5804-5817. PubMed ID: 38074914
[TBL] [Abstract] [Full Text] [Related]
6. An evaluation of 20-year survival of radiofrequency ablation for hepatocellular carcinoma as first-line treatment.
Bai XM; He ZH; Wu H; Yang W; Wang S; Zhang ZY; Wu W; Yan K; Chen MH; Nahum Goldberg S
Eur J Radiol; 2023 Nov; 168():111094. PubMed ID: 37738836
[TBL] [Abstract] [Full Text] [Related]
7. Lung immune prognostic index‑based nomogram for recurrence of hepatocellular carcinoma after postoperative adjuvant TACE.
Liang Y; Yang R; Shang J; Zhong D; Yang Q; Su Y; Shi Y; Huang X
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16461-16471. PubMed ID: 37707573
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of RETREAT and CCFSS Scoring Systems for Risk Estimation of Hepatocellular Carcinoma Recurrence After Radical Resection.
Zhang S; Zhang X; Mo C; Luo Y
Altern Ther Health Med; 2023 Nov; 29(8):694-698. PubMed ID: 37678878
[TBL] [Abstract] [Full Text] [Related]
9. Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection.
Lui GC; Hui VW; Sze SF; Wong BC; Cheung C; Lee MP; Yip TC; Tse YK; Lai JC; Chan HL; Wong VW; Hui YT; Wong GL
Aliment Pharmacol Ther; 2023 Oct; 58(8):814-823. PubMed ID: 37515399
[TBL] [Abstract] [Full Text] [Related]
10. A gadoxetic-acid enhancement flux analysis of small liver nodules (≤2 cm) in patients at high risk of hepatocellular carcinoma.
Chen H; Wang J; Guo T; Ye T; Wan J; Sun P; Pan F; Yang L
Eur J Radiol; 2023 Aug; 165():110911. PubMed ID: 37300937
[TBL] [Abstract] [Full Text] [Related]
11. MRI-based radiomics model and nomogram for predicting the outcome of locoregional treatment in patients with hepatocellular carcinoma.
Wang Y; Liu Z; Xu H; Yang D; Jiang J; Asayo H; Yang Z
BMC Med Imaging; 2023 May; 23(1):67. PubMed ID: 37254089
[TBL] [Abstract] [Full Text] [Related]
12. Regorafenib compared to nivolumab after sorafenib failure in patients with hepatocellular carcinoma: A systematic review and meta-analysis.
Yang S; Zhou Y; Zeng L
Adv Clin Exp Med; 2023 Aug; 32(8):839-845. PubMed ID: 37140014
[TBL] [Abstract] [Full Text] [Related]
13. Characterization of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid-enhanced MRI via contrast-enhanced ultrasound using perfluorobutane.
Bae JS; Lee JY; Suh KS; Hong SK; Yoon JH; Kim YJ; Yu SJ; Lee JH; Cho EJ; Lee YB; Han JK
Abdom Radiol (NY); 2023 Jul; 48(7):2321-2330. PubMed ID: 37097451
[TBL] [Abstract] [Full Text] [Related]
14. Impact of perineural invasion on the outcome of patients with synchronous colorectal liver metastases treated with neoadjuvant chemotherapy and surgery.
Zozaya G; Cienfuegos JÁ; Martí-Cruchaga P; Hernández-Lizoain JL; Baixauli J; Pardo F; Robledano R; Rodríguez J; Arbea L; Rotellar F
Clin Transl Oncol; 2023 Aug; 25(8):2523-2531. PubMed ID: 37027061
[TBL] [Abstract] [Full Text] [Related]
15. Five-year overall survival with ipilimumab and stereotactic ablative radiotherapy for metastatic disease.
He K; Hong DS; Tang C; Sezen D; Cox L; Maleki A; Bertolet G; Nguyen QN; Comeaux NI; Schuda L; Chen D; Welsh JW
Radiother Oncol; 2023 Jun; 183():109618. PubMed ID: 36921766
[TBL] [Abstract] [Full Text] [Related]
16. Non-occupational physical activity and risk of cardiovascular disease, cancer and mortality outcomes: a dose-response meta-analysis of large prospective studies.
Garcia L; Pearce M; Abbas A; Mok A; Strain T; Ali S; Crippa A; Dempsey PC; Golubic R; Kelly P; Laird Y; McNamara E; Moore S; de Sa TH; Smith AD; Wijndaele K; Woodcock J; Brage S
Br J Sports Med; 2023 Aug; 57(15):979-989. PubMed ID: 36854652
[TBL] [Abstract] [Full Text] [Related]
17. Peripheral immune factors aiding clinical parameter for better early recurrence prediction of hepatocellular carcinoma after thermal ablation.
Fan F; Dong G; Han C; Ding W; Li X; Dong X; Wang Z; Liang P; Yu J
Int J Hyperthermia; 2023; 40(1):2172219. PubMed ID: 36775652
[TBL] [Abstract] [Full Text] [Related]
18. Hsa-miR-22-3p inhibits liver cancer cell EMT and cell migration/ invasion by indirectly regulating SPRY2.
Cui S; Chen Y; Guo Y; Wang X; Chen D
PLoS One; 2023; 18(2):e0281536. PubMed ID: 36749775
[TBL] [Abstract] [Full Text] [Related]
19. [Noninvasive assessment of the risk of esophageal variceal bleeding from noncirrhotic portal hypertension].
Xu HF; Wang Y; He FL; Fan ZH; Liu H; Yang YP; Jia JD; Liu FQ; Ding HG
Zhonghua Gan Zang Bing Za Zhi; 2022 Oct; 30(10):1092-1099. PubMed ID: 36727234
[No Abstract] [Full Text] [Related]
20. A multi-scale, multi-region and attention mechanism-based deep learning framework for prediction of grading in hepatocellular carcinoma.
Wei J; Ji Q; Gao Y; Yang X; Guo D; Gu D; Yuan C; Tian J; Ding D
Med Phys; 2023 Apr; 50(4):2290-2302. PubMed ID: 36453607
[TBL] [Abstract] [Full Text] [Related]
[Next]
